4 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... inhibitors during ... Drug interactions ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
dose of another drug ... in that class. ... recalls, this drug ... #Table #Dosing ... #Pharmacology #Dose
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... dose of a given drug ... the timing and dosing ... dose of a given drug ... ticagrelor #prasugrel #pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug ... to hypertension Antiplatelets ... Antiarrhythmic Drugs ... supplementals #herbal #pharmacology ... #DDI #table #cardiology